Hemorrhage or hypotension induces extensive Foslike immunoreactivity in the magnocellular neurosecretory cells in the supraoptic nucleus of the hypothalamus in rat, especially in the vasopressin neurons. The present study was to explore the neurotransmitter mediating this effect. Microinfusion of the alpha-adrenergic blocker into the supraoptic nucleus reduced the hypotension-induced Fos, whereas beta-antagonist did not affect it significantly. Alpha1-and alpha2-antagonist, prazosin and yohimbine, both reduced the Fos-positive cell counts. However, the effective dosage of yohimbine was much larger. Alpha -agonist, methoxamine, induced abundant Fos-like immunoreactivity in the vasopressin cells in this nucleus, while beta-and alpha2-agonist did not elicit such effect. Administration of the noradrenergic re-uptake inhibitor, desipramine, to this nucleus to locally accumulate the' spontaneously released noradrenaline from the nerve terminals also induced Fos expression, mostly in the vasopressin cells.
INTRODUCTION
Hemorrhage or hypotension induces extensive Fos-like immunoreactivity (FLI) in the paraventricular nucleus (PV) and supraoptic nucleus (SO) of the hypothalamus in the rat [l, 2] . Double labeling the FLI-positive cells with anti-oxytocin or antivasopressin serum shows that FLI is mostly expressed in the vasopressin (VP) cells rather than in the oxytocin (OT) cells, especially in the SO [2] . c-fos is one of the family members of the immediate-early genes which have been implicated as third messengers in the intracellular signal transduction systems [3, 4] . It is of interest to reveal the chemical pathway through which extracellular stimuli initiate the activity of third messengers in different kind of nerve cells. The hypotension-induced FLI expression in the magnocellular neurosecretory neurons may serve as a model. As an initial step, we here investigated the neurotransmitters and receptors involved in the hypotension-induced FLI expression in the supraoptic nucleus.
The preferential expression of FLI in the VP cells of the SO indicates that this effect is induced through a specific neural pathway. A pathway has been demonstrated from the nucleus tractus solitarius, which receives the message of baroreceptor unloading, via the ventrolateral medulla to those portions of the magnocellular divisions of the SO and PV in which VP cells are concentrated [5] [6] [7] [8] [9] . The latter part of the pathway has been shown to be noradrenergic. The phasically firing putative VP neurons in the SO and PV are activated by electrical stimulation in both the caudal ventrolateral medulla and NTS [7, 10, 11, 12] . Lesions of noradrenergic cells in the ventrolateral medulla reduce the vasopressin release evoked by hemorrhage [6, 13] . In this context, noradrenaline (NA) seems pertinent to be the first candidate for us to explore, Preliminary work of the present study has been reported in an abstract [14] .
MATERIALS AND METHODS
Male Sprague-Dawley rats (200-300 g) were anesthetized with sodium pentobarbital (60 mg/kg, i.p.). The right femoral artery was cannulated with a PE 50 tubing which was connected through a pressure transducer to a DC amplifier and pen recorder for measurement of blood pressure (BP). The right femoral vein was cannulated for intravenous infusion of sodium nitroprusside (SNP, 2 mg/ ml) to lower the BP when needed. During the hypotension procedure BP was suddenly lowered by a surge of infusion of SNP, then the infusion was kept at a constant rate (10 μl/min).
Rats were divided into 4 control groups and 17 experimental groups (n=5 or 6 in each group) subjected to different dose of antagonists or agonists (see below). In these experiments the head of the rat was mounted on a Narishge stereotaxic instrument. A microsyringe was fixed on a micromanipulator, and the tip of needle was aimed at 1.4 mm posterior to bregma, 1.8 mm lateral to midline, and 9 mm below the skull surface. The rate of microinfusion was 10 nl/min. The antagonists were microinfused 10 min before hypotension and continued for another 20 min during and after hypotension. The duration of hypotension in such experiments was kept at 60 mmHg for 15 min, then the BP was returned to normal by stopping the infusion of SNP. Animals were sacrificed 60 min after the beginning of hypotension. For each antagonist, rats were divided into 3 groups (n=6 in each group): (1) Control, i.e. saline+hypotension; (2) lower dose+hypotension; (3) higher dose+hypotension. The agonists were microinfused to the SO in the rats without hypotension. In each rat 0.5 μl of agonist was given slowly in a period of 50 min, and the animal was sacrificed after another 30 min. BP was monitored to make sure the agonist not causing fluctuation of BP For each agonist, rats were divided into 3 groups (n=5 in each group) administrated with lower, middle and higher doses respectively. A separate group (n=5) was microinfused with saline only;
At the end of experiments rats were intracardially perfused with heparinized phosphate-buffered saline (PBS) followed by 4% paraformaldehyde in PBS. Brains were post-fixed for 2 h, and kept in cool PBS (5℃) over night, then sectioned coronally at 40 μm thickness with a vibratome and processed for immunocytochemistry.
Immunocytochemistry
For Fos immunocytochemistry the main procedures were as follows. (1) To double-stain the sections for Fos and VP or OT, (1) the sections were incubated in normal rabbit serum as above for blocking non-specific protein-binding groups; (2) incubated in primary anti-Fos serum (from sheep, Cambridge, OA-11-823, 1:1000) mixed with primary anti-VP or anti-OT serum (from rabbit, 1:1000; provided by Dr. Changling Lu of the Second Military Medical University at Shanghai. The high specificity of these antisera had been characterized previously [15, 16] ) for 72 h in 4℃; (3), (4) (5) as above for developing FLI; (6) sections were incubated with biotinylated goat anti-rabbit IgG (1:200, Vector) for 2 h; (7) incubated with avidin-conjugated fluorescein isothiocyanate (1:100, Sigma) for 30 min to show the VP or OT immunoreactivity. A fluorescence microscope (Leitz) with appropriate filters was used.
As staining controls, the primary antisera were either omitted from the staining procedures or pre-absorbed with antigens, i.e., Fos synthetic peptide (Cambridge, OP-11-3210), argininevasopressin (Sigma) or oxytocin (Sigma). No staining was seen in these controls.
Statistics
The total FLI-positive cells in the SO on 12 consecutive sections containing SO were counted with a manually operated counter guided by a grid in the eye piece. The data were expressed as means ± S.D. The results were analyzed by means of Rank Sum test.
Materials
Sodium nitroprusside (Sigma); phentolamine methanesulfonate (Sigma); prazosin HCl (Sigma, dissolved in dimethylsulfoxide, then diluted to the intended concentration with PBS. The final dilution of dimethylsulfoxide did not exceed 0.01% v/v); yohimbine HCl (Sigma); DL-propranolol HCl (Sigma); methoxamine HCl (Sigma); clonidine HCl (Sigma); (-)isoproterenol HCl (Sigma); desipramine HCl (Sigma).
RESULTS

Duration of hypotension
The duration of hypotension employed in previous work for induction of FLI was 1 h [2] . It is not convenient for studying the action of different antagonists, since some drug effect may not last for such a long period. For this reason, the effects of 5 and 15 min of hypotension were compared with that of 60 min, provided that all animals were perfused at 1 h after the beginning of hypotension. The counts of FLI-positive cells induced by 5, 15 and 60 min hypotension was 2178 ± 625, 2270 ± 448 and 2301 ± 438 respectively (n=5), the differences among them being not significant. We used a duration of 15 min hypotension in the following experiments.
Time course of FLI expression
Given the duration of hypotension being 15 min, animals were perfused respectively at 0, 15, 30, 60, 120, 180, 240, 360, 480 min and 24 h after the beginning of hypotension. Fig 1 shows that the peak of FLI-positive cell counts is at 180 min. At 480 min, it falls almost to the baseline.
Effects of adrenergic antagonists
We tried the α-adrenergic antagonist, phentolamine, and β-adrenergic antagonist, propranolol first. Microinfusion of phentolamine (1 and 5 nmol in 0.3 μl, n=6) directed to the right SO diminished the FLI expression induced by hypotension, whereas microinfusion of propranolol (1 and 5 nmol in 0.3 μl, n=6) did not affect the FLI-positive cell counts significantly (Fig 2, Fig 3) . Microinfusion of α 1 -antagonist, prazosin (0.1 and 0.5 nmol in 0.3 μl, n=6), or α 2 -antagonist, yohimbine (1 and 5 nmol in 0.3 μl, n=6 ) both reduced the FLI-positive cell counts (Fig 2, Fig 3) . However the effective dosage of yohimbine was higher.
Fig 2.
Effects of microinfusion of adrenergic antagonists (propranolol, phentolamine, prazosin and yohimbine) into the supraoptic nucleus on the FLI in this nucleus induced by 15 min hypotension. The rats were sacrificed 1 h after start of hypotension. In the controls (C) the rats were treated by microinfusion of saline into the supraoptic nucleus before and during hypotension. The figure under each column denotes dose in nmol. n=6. *, P < 0.05; **, P < 0.01; ***, P < 0.001. (Fig 4, Fig 5) . Comparisons were all made between agonist treated groups and the saline group, n=5. ** P < 0.01; *** P < 0.001.
Induction of FLI expression by NA re-uptake inhibitor
Administration of noradrenaline re-uptake inhibitor, desipramine (5 nmol in 0.5 μl, n=5) to the SO was performed to see the effect of local accumulation of spontaneously released noradrenaline from the nerve terminals. The time taken for microinfusion and perfusion of the animal was like that for agonists described in the Materials and Methods. FLI was induced in all five animals (mean ± S.D. was 1241 ± 457. Comparison between desipramine group and saline group showed highly signigicant difference, P < 0.01). Cell type expressing FLI following agonists or re-uptake inhibitor Double staining the FLI-positive cells with anti-VP serum or anti-OT serum respectively in every other section showed that the FLI in the SO induced either by methoxamine (10 nmol) or by desipramine (5 nmol) was largely expressed in the VP-positive cells. There were 986 ± 183 out of 1406 ± 293 (methoxamine) and 823 ± 268 out of 1241 ± 457 (desipranfine) FLI-positive nuclei in the VP neurons. Fig  6A shows numerous fluorescent VP neurons containing dark FLI-positive nucleus, while few OT neurons in the Fig 6C containing the dark nucleus following treatment of desipramine. The result of microinfusion of methoxamine was the same. These results are consistent with that after hypotension [23] . 
DISCUSSION
The present results suggest that the FLI-induction by hypotension in the magnocellular endocrine cells in the SO is mediated, at least partially, by an adrenergic pathway via α 1 -receptors. This finding is consistent both with anatoinical data [5, 8, 9, 17] and electrophysiological evidence [7, 10, 11, 12, 18, 19, 20] . The SO contains a dense catecholamine terminal innervation due mainly to noradrenaline [8, 17, 21] and arising primarily from the A1 noradrenergic cell group in the ventrolateral medulla [8, 10, 17] . The NTS projects both to A1 cell group and to the SO directly [5, 7, 8, 11, 12] . The electrophysiological experiments showed that the excitatory action of noradrenaline upon the VP cells in the SO was mainly due to activation of α 1 -receptors [18, 20] . However, it is curious that the adrenergic antagonists did not affect the increased spike activity of putative VP cells in the SO evoked by stimulation of the A1 noradrenergic region [22] . The authors claimed that the increased spike activity so evoked was mediated by ATP [23] . We have not examined the role played by ATP in Fos -induction yet. Nevertheless, stimulation of the A1 region does not necessarily excite the neural pathway underlying the physiological effect of hypotension, owing to that different parameters of stimuli may activate different nerve cells and fibers. Secondly, in the induction of Fos expression, increasing frequency of action potentials may not be the crucial factor [24] . The crucial one is activation of receptors which does not necessarily cause increasing spike activity but may produce depolarization of the membrane and/or cascades of intracellular chemical reactions, some of which may lead to Fos expression.
The blockade of FLI expression in the SO by adrenergic antagonists is far from complete (Fig 4, Fig 5) . It seems that other neurotransmitters may associate with NA to mediate the FLI-induction. Some 30 neurotransmitters and neuropeptides have been identified in the PV and SO, some in cell bodies, some in nerve terminals [9, 25] . Among the listed transmitters, noradrenaline, acetylcholine, glutamate, 5-hydroxytryptamine, histamine, dopamine and γ-aminobutyric acid have drawn attention of many investigators [25] . Day et al found that ATP may mediate the excitatory inputs from A1 region to VP cells in the SO [23] . The role played by ATP in the FLI induction in the SO also remains to be investigated.
There is evidence that stress-induced release of NA interacts with postsynaptic β-adrenergic receptors, not withα-receptors, resulting in induction of c-fos mRNA in the rat brain [26] . This result seems in contradiction with the present one. But what they observed is the mRNA in the whole brain. It has been demonstrated that the excitatory effect of β-receptor activation is mainly in the hippocampus and cerebral cortex [27] . The size of the SO, even together with the PV, is so small in comparison with the hippocampus and cerebral cortex that the effect of NA on α-receptors in the SO or PV must be masked by that on β-receptor in the whole brain preparation. However, this result together with ours indicate that Fos expression is induced through different receptors in different nerve cells. It has been known that the β-receptor activation results in activation of adenylate cyclase, and α 1 -receptor are coupled to phospholipase C and phosphoinositide turnover [27] . These facts suggest that Fos expression is induced through different chemical pathways in different type of neurons.
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